Sports Health. 2021 Sep-Oct;13(5):490-501. doi: 10.1177/19417381211003515. Epub 2021 Apr 22.
There is currently no evidence-based consensus on how to treat a full-thickness, symptomatic articular cartilage injury of the patella, although numerous treatment options are available.
To systematically evaluate the functional outcomes after operative treatment of patellar cartilage lesions. Our secondary purpose was to evaluate radiographic outcomes after treatment.
PubMed, Cochrane, and Embase.
Studies published between January 1, 1990 and December 31, 2018 that included patient-reported functional outcomes for patients after operative treatment of patellar chondral defects at a minimum 2-year follow-up were included.
Systematic review.
Level 4.
MINORS (Methodological Index for Non-Randomized Studies) score, level of evidence, sample size, demographic data, follow-up data, intervention, functional outcome scores, and magnetic resonance imaging (MRI) data were collected.
The review identified 10 studies and 293 patients receiving cartilage restoration procedures for patellar chondral defects with extractable clinical and radiographic results and data on complications and reoperations. All treatments (autologous chondrocyte implantation [ACI], matrix-induced ACI [MACI], autologous osteochondral transplantation [AOT]) utilized in the management of patellar chondral lesions, with the exception of isolated particulated juvenile articular cartilage, demonstrated statistically significant improvements in functional outcome scores compared with preoperative measurements at a minimum of 2-year follow-up. Postoperative MRIs were obtained in 6 studies and found that regardless of treatment, moderate-to-complete infill of patellar cartilage lesions was seen in the majority of patients. While failure rates were low for the various treatment modalities, rates of reoperation were substantial, with up to 40% to 60% reoperation rate seen after ACI.
Patients treated with ACI, MACI, and AOT all demonstrated statistically significant improvements in functional outcome scores with radiographic evidence of healing at minimum of 2-year follow-up. Evidence is insufficient to recommend one particular treatment over another.
目前对于全层、有症状的髌骨软骨关节内损伤尚无循证医学共识,尽管有许多治疗方法可供选择。
系统评估手术治疗髌骨软骨病变的功能结果。我们的次要目的是评估治疗后的影像学结果。
PubMed、Cochrane 和 Embase。
纳入了 1990 年 1 月 1 日至 2018 年 12 月 31 日期间发表的研究,这些研究包括接受髌骨软骨缺损手术治疗的患者在至少 2 年随访时的患者报告功能结果。
系统评价。
4 级。
MINORS(非随机研究方法学指数)评分、证据水平、样本量、人口统计学数据、随访数据、干预措施、功能评分和磁共振成像(MRI)数据。
综述共纳入 10 项研究,共 293 例患者接受了软骨修复术治疗髌骨软骨缺损,这些研究具有可提取的临床和影像学结果以及并发症和再次手术的数据。除了孤立的颗粒状幼年关节软骨外,用于治疗髌骨软骨病变的所有治疗方法(自体软骨细胞移植[ACI]、基质诱导的 ACI[MACI]、自体骨软骨移植[AOT]),与术前测量相比,在至少 2 年的随访中,均显示出统计学上显著的功能评分改善。6 项研究中获得了术后 MRI,发现无论治疗方法如何,大多数患者的髌骨软骨病变均有中到完全填充。虽然各种治疗方法的失败率较低,但再次手术率很高,ACI 后高达 40%至 60%的患者需要再次手术。
ACI、MACI 和 AOT 治疗的患者在功能评分上均有统计学显著改善,影像学上显示至少 2 年的随访中有愈合迹象。证据不足以推荐一种治疗方法优于另一种。